Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia.

Zhan, Min; Liu, Ting; Zhang, Zhou; Wang, Guoqiang; Cao, Zhongqiang; Li, Xuejuan; Zeng, Hongwu; Mai, Huirong; Chen, Zebin

Zhan, Min; Liu, Ting; Zhang, Zhou; Wang, Guoqiang; Cao, Zhongqiang; Li, Xuejuan; Zeng, Hongwu; Mai, Huirong; Chen, Zebin.

Afiliación

Zhan M; Department of Pharmacy, Shenzhen Children's Hospital, Shenzhen, China.
Liu T; Department of Pharmacy, Shenzhen Children's Hospital, Shenzhen, China.
Zhang Z; Department of Pharmacy, Shenzhen Children's Hospital, Shenzhen, China.
Wang G; Department of Pharmacy, Shenzhen Children's Hospital, Shenzhen, China.
Cao Z; Department of Pharmacy, Shenzhen Children's Hospital, Shenzhen, China.
Li X; Department of Pharmacy, Shenzhen Children's Hospital, Shenzhen, China.
Zeng H; Department of Radiology, Shenzhen Children's Hospital, Shenzhen, China.
Mai H; Department of Hematology/Oncology, Shenzhen Children's Hospital, Shenzhen, China.
Chen Z; Department of Pharmacy, Shenzhen Children's Hospital, Shenzhen, China.

Front Pediatr ; 11: 1153767, 2023.

Article en En | MEDLINE | ID: mdl-37384310

Palabras clave

acute lymphoblastic leukemia; hematological toxicities; methotrexate; miRNA polymorphism; pediatric

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pediatr Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google